Next-generation personalized drug discovery: the tripeptide ghk hits center stage in chronic obstructive pulmonary disease
This issue highlights key shifts shaping global and Korean markets: The global pharmaceutical markets pivot toward metabolic diseases and the post-GLP-1 competitive era China surpassing the US in new drug approvals, intensifying global biotech competition Rapid growth of Koreas CGM market, alongside continued import dependence Major outcomes from Koreas pan-ministerial medical device R&D program and the launch of its second phase A 1 trillion government investment in medical AI and expanded real-world implementation MFDS regulatory updates, including new drug & biotech guidelines, digital clinical data guidance, updated trial site designations, WHO WLA recognition, and direct government supply of rare medicines Together, these developments signal a more data-driven, innovation-focused, and globally connected clinical and regulatory environment
And protein shakes, fish, and seafood are always good choices for lean protein
A peptide calculator converts a vial's peptide mass and the amount of bacteriostatic (BAC) water you add into a concentration (mg/mL) and tells you exactly how many insulin-syringe units equal your target dose
Unlike taking exogenous melatonin, which can suppress endogenous production over time, epitalon theoretically supports the pineal glands own function
SNAC, sodium N-(8-[2-hydroxybenzoyl]amino) caprylate
